Trial Outcomes & Findings for Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy (NCT NCT01048125)

NCT ID: NCT01048125

Last Updated: 2016-11-23

Results Overview

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

2 participants

Primary outcome timeframe

2 years

Results posted on

2016-11-23

Participant Flow

2 participants were consented, but due to difficulty in recruitment and resource restraints the study did not progress as expected and was closed.

Participant milestones

Participant milestones
Measure
Study Group
Subjects with documented stress cardiomyopathy who would serve as the study group. Sympathetic Nerve Activity; Mental StrCold Pressor Testess Test (Color Word Test); The Modified Oxford Technique for Baroreflex Sensitivity; Cold Pressor Test; Echocardiographic evaluation
Control
Control subjects will be age and sex matched otherwise healthy people with no prior cardiac disease or other severe medical conditions. Sympathetic Nerve Activity; Mental Stress Test (Color Word Test); The Modified Oxford Technique for Baroreflex Sensitivity; Cold Pressor Test; Echocardiographic evaluation Sympathetic Nerve Activity: Resting Sympathetic Nerve Activity Mental Stress Test (Color Word Test): A printed word will be shown to the subject, displayed in a color different from the color it actually names. The subject will be asked to say the color that the word is printed in as quickly as possible. For example if the word "green" is written in blue ink, they will say "blue." This mental stress procedure will be used to cause brief changes in heart rate and blood pressure. The Modified Oxford Technique for Baroreflex Sensitivity: Sodium nitroprusside (100 µg) will be infused intravenously as a bolus, followed 60 seconds later by a bolus of phenylephrine hydrochloride
Overall Study
STARTED
0
0
Overall Study
COMPLETED
0
0
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Study Group
Subjects with documented stress cardiomyopathy who would serve as the study group. Sympathetic Nerve Activity; Mental StrCold Pressor Testess Test (Color Word Test); The Modified Oxford Technique for Baroreflex Sensitivity; Cold Pressor Test; Echocardiographic evaluation
Control
Control subjects will be age and sex matched otherwise healthy people with no prior cardiac disease or other severe medical conditions. Sympathetic Nerve Activity; Mental Stress Test (Color Word Test); The Modified Oxford Technique for Baroreflex Sensitivity; Cold Pressor Test; Echocardiographic evaluation
Total
Total of all reporting groups
Age, Categorical
<=18 years
0
n=27 Participants
Age, Categorical
Between 18 and 65 years
0
n=27 Participants
Age, Categorical
>=65 years
0
n=27 Participants
Gender
Female
0
n=27 Participants
Gender
Male
0
n=27 Participants
Region of Enrollment
United States
0
n=27 Participants

PRIMARY outcome

Timeframe: 2 years

Population: Due to difficulty in recruitment and resource restraints the study did not progress as expected and was closed.

Outcome measures

Outcome data not reported

Adverse Events

Study Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Anand Chockalingam

University of Missouri-Columbia

Phone: 573/882-2296

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place